NCT01411176View on ClinicalTrials.gov

Phase III Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy

PHASE3CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

June 30, 2012

Conditions
Gastric Cancer
Interventions
DRUG

Menthol

20 mL NPO-11 in a prefilled plastic syringe

DRUG

Placebo

The placebo is included same additives as active comparator.

Trial Locations (1)

101-0031

Nihon Pharmaceutical Co., Ltd, Tokyo

Sponsors
All Listed Sponsors
lead

Nihon Pharmaceutical Co., Ltd

INDUSTRY